OpenAI’s nonprofit arm has committed at least $1 billion over the next year to cure-related research and resilience projects, a sharp expansion of Sam Altman’s health-focused messaging and a sign the company is moving beyond pure model development into broader scientific infrastructure.
OpenAI’s latest move is not a product launch. It is a capital-and-policy signal: the company says it will commit at least $1 billion to AI research aimed at disease, while opening grants and credits for outside work that builds on its new industrial-policy agenda.
OpenAI has committed at least $1 billion to its nonprofit arm over the next year and named new leaders as it expands its work in AI safety, life sciences, and civil society.
OpenAI said on March 31, 2026 that it closed a $122 billion funding round, then used the announcement to outline a broader strategy centered on compute, enterprise growth, and a unified AI superapp.
